Latest news & insights
Spring Budget: R&D tax relief rate announcement
In the Spring Budget, the Chancellor has announced an enhanced R&D tax relief rate for ‘R&D intensive SMEs.’ Professor Alan Boyd, CEO and president of Boyds, responds to the news.
Further growth for regulatory affairs team at Boyds with appointment of Harriet Edwards
We are pleased to announce the appointment of experienced regulatory professional, Harriet Edwards, in response to a sustained rise in demand for specialist regulatory services
Rare Disease Day: Gene therapy trends and innovation for rare diseases
An article published in Med-Tech Innovation and authored by Eamonn McGowran, explains the developments in regulation for Medical devices.
Eamonn McGowran explains developments in regulation for medical devices in Med-Tech Innovation article
An article published in Med-Tech Innovation and authored by Eamonn McGowran, explains the developments in regulation for Medical devices.
Dr Karen Mullen interviewed for pharmaphorum article
Dr Karen Mullen, Chief Medical Officer at Boyds, recently sat down with pharmaphorum, a leading online destination for healthcare and pharmaceutical industry news.
Boyds regulatory affairs article published by Drug Discovery World
An article authored by Dr Julie Warner, Vice President of Regulatory Affairs, has been featured by Drug Discovery World – the multi-platform global voice for the drug discovery community.
